Genetic Test Helps Predict Risk of Prostate Cancer Recurrence

Submitted by Leslie Lingaas on May 9, 2013 at 3:57 pm

Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.. 

Dr. Carroll and UCSF Urology TeamA study using tissue samples from men who underwent surgical removal of the prostate at UC San Francisco confirmed that a genetic test that measures cell cycle progression (CCP) — an indicator of how rapidly cancer cells are growing and dividing — can be a useful tool for predicting who will have a recurrence of the disease, especially when combined with existing information from laboratory and pathology tests. 

Click here to read full story from UCSF